Phytochemical-mediated Efferocytosis and Autophagy in Inflammation Control

Overview

Journal Cell Death Discov

Date 2024 Dec 18

PMID 39695119

Authors

Asma Vafadar

Amir Tajbakhsh

Fatemeh Hosseinpour-Soleimani

Amir Savardshtaki

Mohammad Hashem Hashempur

Affiliations

Soon will be listed here.

Abstract

Efferocytosis, the clearance of apoptotic cells, is a critical process that maintains tissue homeostasis and immune regulation. Defective efferocytosis is linked to the development of chronic inflammatory conditions, including atherosclerosis, neurological disorders, and autoimmune diseases. Moreover, the interplay between autophagy and efferocytosis is crucial for inflammation control, as autophagy enhances the ability of phagocytic cells. Efficient efferocytosis, in turn, regulates autophagic pathways, fostering a balanced cellular environment. Dysregulation of this balance can contribute to the pathogenesis of various disorders. Phytochemicals, bioactive compounds found in plants, have emerged as promising therapeutic agents owing to their diverse pharmacological properties, including antioxidant, anti-inflammatory, and immunomodulatory effects. This review aims to highlight the pivotal role of phytochemicals in enhancing efferocytosis and autophagy and explore their potential in the prevention and treatment of related disorders. This study examines how phytochemicals influence key aspects of efferocytosis, including phagocytic cell activation, macrophage polarization, and autophagy induction. The therapeutic potential of phytochemicals in atherosclerosis and neurological diseases is highlighted, emphasizing their ability to enhance efferocytosis and autophagy and reduce inflammation. This review also discusses innovative approaches, such as nanoformulations and combination therapies to improve the targeting and bioavailability of phytochemicals. Ultimately, this study inspires further research and clinical applications in phytochemical-mediated efferocytosis enhancement for managing chronic inflammatory and autoimmune conditions.

References

Boonrueng P, Dasuni Wasana P, Hasriadi , Vajragupta O, Rojsitthisak P, Towiwat P . Combination of curcumin and piperine synergistically improves pain-like behaviors in mouse models of pain with no potential CNS side effects. Chin Med. 2022; 17(1):119. PMC: 9590184. DOI: 10.1186/s13020-022-00660-1. View

Hall-Roberts H, Di Daniel E, James W, Davis J, Cowley S . In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages. J Vis Exp. 2021; (168). DOI: 10.3791/62217. View

Karaji N, Sattentau Q . Efferocytosis of Pathogen-Infected Cells. Front Immunol. 2018; 8:1863. PMC: 5743670. DOI: 10.3389/fimmu.2017.01863. View

Vandivier R, Fadok V, Hoffmann P, Bratton D, Penvari C, Brown K . Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest. 2002; 109(5):661-70. PMC: 150889. DOI: 10.1172/JCI13572. View

Wu J, Zhang L, Chen Y, Yu S, Zhao Y, Zhao J . Curcumin pretreatment and post-treatment both improve the antioxidative ability of neurons with oxygen-glucose deprivation. Neural Regen Res. 2015; 10(3):481-9. PMC: 4396114. DOI: 10.4103/1673-5374.153700. View

Zingg J, Hasan S, Cowan D, Ricciarelli R, Azzi A, Meydani M . Regulatory effects of curcumin on lipid accumulation in monocytes/macrophages. J Cell Biochem. 2011; 113(3):833-40. DOI: 10.1002/jcb.23411. View

Doran A, Yurdagul Jr A, Tabas I . Efferocytosis in health and disease. Nat Rev Immunol. 2019; 20(4):254-267. PMC: 7667664. DOI: 10.1038/s41577-019-0240-6. View

Flannagan R, Canton J, Furuya W, Glogauer M, Grinstein S . The phosphatidylserine receptor TIM4 utilizes integrins as coreceptors to effect phagocytosis. Mol Biol Cell. 2014; 25(9):1511-22. PMC: 4004599. DOI: 10.1091/mbc.E13-04-0212. View

Abdi H, Roshanravan M, Mirzavi F, Hosseinzadeh H, Mosaffa F . Crocin's effect on phenotype switching of J774A.1 macrophages depends on their polarization state during exposure. Iran J Basic Med Sci. 2023; 26(12):1431-1437. PMC: 10634050. DOI: 10.22038/IJBMS.2023.70859.15392. View

10.

Cvetanovic M, Ucker D . Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition. J Immunol. 2004; 172(2):880-9. DOI: 10.4049/jimmunol.172.2.880. View

11.

Das S, Owen K, Ly K, Park D, Black S, Wilson J . Brain angiogenesis inhibitor 1 (BAI1) is a pattern recognition receptor that mediates macrophage binding and engulfment of Gram-negative bacteria. Proc Natl Acad Sci U S A. 2011; 108(5):2136-41. PMC: 3033312. DOI: 10.1073/pnas.1014775108. View

12.

Bommelaer G, Laharie D, Nancey S, Hebuterne X, Roblin X, Nachury M . Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2019; 18(7):1553-1560.e1. DOI: 10.1016/j.cgh.2019.08.041. View

13.

Park S, Jung M, Kim H, Lee S, Kim S, Lee B . Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ. 2007; 15(1):192-201. DOI: 10.1038/sj.cdd.4402242. View

14.

Park B, Lee J, Moon H, Lee G, Lee D, Cho J . Co-receptors are dispensable for tethering receptor-mediated phagocytosis of apoptotic cells. Cell Death Dis. 2015; 6:e1772. PMC: 4669715. DOI: 10.1038/cddis.2015.140. View

15.

Rowe S, Clancy J, Wilschanski M . Nasal potential difference measurements to assess CFTR ion channel activity. Methods Mol Biol. 2011; 741:69-86. PMC: 3760477. DOI: 10.1007/978-1-61779-117-8_6. View

16.

Vafadar A, Vosough P, Jahromi H, Tajbakhsh A, Savardshtaki A, Butler A . The role of efferocytosis and transplant rejection: Strategies in promoting transplantation tolerance using apoptotic cell therapy and/or synthetic particles. Cell Biochem Funct. 2023; 41(8):959-977. DOI: 10.1002/cbf.3852. View

17.

Ait-Oufella H, Kinugawa K, Zoll J, Simon T, Boddaert J, Heeneman S . Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation. 2007; 115(16):2168-77. DOI: 10.1161/CIRCULATIONAHA.106.662080. View

18.

Hou Y, Plett P, Ingram D, Rajashekhar G, Orschell C, Yoder M . Endothelial-monocyte-activating polypeptide II induces migration of endothelial progenitor cells via the chemokine receptor CXCR3. Exp Hematol. 2006; 34(8):1125-32. DOI: 10.1016/j.exphem.2006.05.021. View

19.

Rezazadeh-Shojaee F, Ramazani E, Kasaian J, Tayarani-Najaran Z . Protective effects of 6-gingerol on 6-hydroxydopamine-induced apoptosis in PC12 cells through modulation of SAPK/JNK and survivin activation. J Biochem Mol Toxicol. 2021; 36(2):e22956. DOI: 10.1002/jbt.22956. View

20.

McCubbrey A, Curtis J . Efferocytosis and lung disease. Chest. 2013; 143(6):1750-1757. PMC: 3673667. DOI: 10.1378/chest.12-2413. View